• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症通过β-肾上腺素受体诱导应激性回肠炎,并促进有助于癌变的生态失调。

Cancer Induces a Stress Ileopathy Depending on β-Adrenergic Receptors and Promoting Dysbiosis that Contributes to Carcinogenesis.

机构信息

Gustave Roussy, ClinicObiome, Villejuif, France.

INSERM U1015, Equipe Labellisée - Ligue Nationale contre le Cancer, Villejuif, France.

出版信息

Cancer Discov. 2022 Apr 1;12(4):1128-1151. doi: 10.1158/2159-8290.CD-21-0999.

DOI:10.1158/2159-8290.CD-21-0999
PMID:34930787
Abstract

UNLABELLED

Gut dysbiosis has been associated with intestinal and extraintestinal malignancies, but whether and how carcinogenesis drives compositional shifts of the microbiome to its own benefit remains an open conundrum. Here, we show that malignant processes can cause ileal mucosa atrophy, with villous microvascular constriction associated with dominance of sympathetic over cholinergic signaling. The rapid onset of tumorigenesis induced a burst of REG3γ release by ileal cells, and transient epithelial barrier permeability that culminated in overt and long-lasting dysbiosis dominated by Gram-positive Clostridium species. Pharmacologic blockade of β-adrenergic receptors or genetic deficiency in Adrb2 gene, vancomycin, or cohousing of tumor bearers with tumor-free littermates prevented cancer-induced ileopathy, eventually slowing tumor growth kinetics. Patients with cancer harbor distinct hallmarks of this stress ileopathy dominated by Clostridium species. Hence, stress ileopathy is a corollary disease of extraintestinal malignancies requiring specific therapies.

SIGNIFICANCE

Whether gut dysbiosis promotes tumorigenesis and how it controls tumor progression remain open questions. We show that 50% of transplantable extraintestinal malignancies triggered a β-adrenergic receptor-dependent ileal mucosa atrophy, associated with increased gut permeability, sustained Clostridium spp.-related dysbiosis, and cancer growth. Vancomycin or propranolol prevented cancer-associated stress ileopathy. This article is highlighted in the In This Issue feature, p. 873.

摘要

未加标签

肠道菌群失调与肠道和肠道外恶性肿瘤有关,但致癌作用如何以及如何使微生物组发生组成性变化使其受益仍然是一个悬而未决的难题。在这里,我们表明恶性过程可导致回肠黏膜萎缩,伴有绒毛微血管收缩,与副交感神经信号对胆碱能信号的优势有关。肿瘤发生的快速发作引起回肠细胞中 REG3γ 的释放爆发,以及短暂的上皮屏障通透性,最终导致明显且持久的以革兰氏阳性梭菌属为主的菌群失调。β-肾上腺素能受体的药理学阻断或 Adrb2 基因、万古霉素的遗传缺陷,或肿瘤携带者与无肿瘤同窝仔的共同饲养,可防止癌症引起的回肠炎,最终减缓肿瘤生长动力学。癌症患者具有这种以梭菌属为主的应激性回肠炎的独特特征。因此,应激性回肠炎是肠道外恶性肿瘤的相关疾病,需要特定的治疗方法。

意义

肠道菌群失调是否促进肿瘤发生以及它如何控制肿瘤进展仍然是悬而未决的问题。我们表明,50%的可移植肠道外恶性肿瘤引发了β-肾上腺素能受体依赖性回肠黏膜萎缩,伴有肠道通透性增加、持续的梭菌属相关菌群失调和癌症生长。万古霉素或普萘洛尔可预防与癌症相关的应激性回肠炎。本文在本期特色文章中重点介绍,第 873 页。

相似文献

1
Cancer Induces a Stress Ileopathy Depending on β-Adrenergic Receptors and Promoting Dysbiosis that Contributes to Carcinogenesis.癌症通过β-肾上腺素受体诱导应激性回肠炎,并促进有助于癌变的生态失调。
Cancer Discov. 2022 Apr 1;12(4):1128-1151. doi: 10.1158/2159-8290.CD-21-0999.
2
Bile acid toxicity in Paneth cells contributes to gut dysbiosis induced by high-fat feeding.胆汁酸毒性在潘氏细胞中导致高脂肪喂养引起的肠道菌群失调。
JCI Insight. 2020 Oct 15;5(20):138881. doi: 10.1172/jci.insight.138881.
3
Secondary bile acid-induced dysbiosis promotes intestinal carcinogenesis.次级胆汁酸诱导的生态失调促进肠道癌变。
Int J Cancer. 2017 Jun 1;140(11):2545-2556. doi: 10.1002/ijc.30643. Epub 2017 Mar 1.
4
Vitamin D Receptor Protects Against Dysbiosis and Tumorigenesis via the JAK/STAT Pathway in Intestine.维生素 D 受体通过肠道中的 JAK/STAT 通路防止肠道菌群失调和肿瘤发生。
Cell Mol Gastroenterol Hepatol. 2020;10(4):729-746. doi: 10.1016/j.jcmgh.2020.05.010. Epub 2020 Jun 1.
5
Ceramide-mediated gut dysbiosis enhances cholesterol esterification and promotes colorectal tumorigenesis in mice.鞘氨醇介导的肠道菌群失调增强胆固醇酯化作用并促进小鼠结直肠肿瘤发生。
JCI Insight. 2022 Feb 8;7(3):e150607. doi: 10.1172/jci.insight.150607.
6
High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity.高脂饮食介导的肠道菌群失调独立于肥胖促进肠道癌变。
Nature. 2014 Oct 23;514(7523):508-12. doi: 10.1038/nature13398. Epub 2014 Aug 31.
7
Gut Microbiota Dysbiosis Drives the Development of Colorectal Cancer.肠道微生物群失调推动结直肠癌的发展。
Digestion. 2021;102(4):508-515. doi: 10.1159/000508328. Epub 2020 Sep 15.
8
Ileal varices and portal hypertensive ileopathy in patients with cirrhosis and portal hypertension.肝硬化和门静脉高压患者的回肠静脉曲张及门静脉高压性回肠病
Gastrointest Endosc. 2004 Nov;60(5):778-83. doi: 10.1016/s0016-5107(04)02049-8.
9
Beta-adrenergic blocker inhibits oral carcinogenesis and reduces tumor invasion.β-肾上腺素能阻滞剂抑制口腔癌的发生并降低肿瘤侵袭性。
Cancer Chemother Pharmacol. 2020 Nov;86(5):681-686. doi: 10.1007/s00280-020-04149-2. Epub 2020 Sep 27.
10
Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer.胆汁酸失调、肠道菌群失调与胃肠道癌症。
Exp Biol Med (Maywood). 2014 Nov;239(11):1489-504. doi: 10.1177/1535370214538743. Epub 2014 Jun 20.

引用本文的文献

1
The gut microbiome in lung cancer: from pathogenesis to precision therapy.肺癌中的肠道微生物群:从发病机制到精准治疗
Front Microbiol. 2025 Aug 20;16:1606684. doi: 10.3389/fmicb.2025.1606684. eCollection 2025.
2
Gut microbiota shapes cancer immunotherapy responses.肠道微生物群塑造癌症免疫治疗反应。
NPJ Biofilms Microbiomes. 2025 Jul 25;11(1):143. doi: 10.1038/s41522-025-00786-8.
3
The microbiota in radiotherapy-induced cancer immunosurveillance.放疗诱导的癌症免疫监视中的微生物群
Nat Rev Clin Oncol. 2025 Jul 14. doi: 10.1038/s41571-025-01052-8.
4
ADRB2 inhibition suppresses cancer immune evasion by regulating tumor SOX10-PD-L1 axis and T cell function.β2肾上腺素能受体(ADRB2)抑制通过调节肿瘤SOX10-PD-L1轴和T细胞功能来抑制癌症免疫逃逸。
J Immunother Cancer. 2025 Jun 12;13(6):e011611. doi: 10.1136/jitc-2025-011611.
5
Gut Microbiota Modulation through Akkermansia spp. Supplementation Increases CAR T-cell Potency.通过补充阿克曼氏菌属调节肠道微生物群可增强嵌合抗原受体(CAR)T细胞的效力。
Cancer Discov. 2025 Sep 4;15(9):1905-1926. doi: 10.1158/2159-8290.CD-24-1230.
6
The gut microbiome as a target in cancer immunotherapy: opportunities and challenges for drug development.肠道微生物群作为癌症免疫治疗的靶点:药物开发的机遇与挑战
Nat Rev Drug Discov. 2025 Jun 2. doi: 10.1038/s41573-025-01211-7.
7
Intestinal Microbiome Modulation of Therapeutic Efficacy of Cancer Immunotherapy.肠道微生物群对癌症免疫治疗疗效的调节作用
Gastroenterol Clin North Am. 2025 Jun;54(2):295-315. doi: 10.1016/j.gtc.2024.10.005. Epub 2025 Jan 24.
8
Sini Powder Alleviates Stress Response and Suppresses Hepatocellular Carcinoma Development by Restoring Gut Microbiota.四逆散通过恢复肠道微生物群减轻应激反应并抑制肝细胞癌发展。
Chin J Integr Med. 2025 May 8. doi: 10.1007/s11655-025-4127-z.
9
Cancer-nervous system crosstalk: from biological mechanism to therapeutic opportunities.癌症-神经系统相互作用:从生物学机制到治疗机遇
Mol Cancer. 2025 May 5;24(1):133. doi: 10.1186/s12943-025-02336-4.
10
Oncobiomics: Leveraging Microbiome Translational Research in Immuno-Oncology for Clinical-Practice Changes.肿瘤生物组学:利用免疫肿瘤学中的微生物组转化研究推动临床实践变革。
Biomolecules. 2025 Mar 31;15(4):504. doi: 10.3390/biom15040504.